AMGN

Amgen Inc.

Healthcare
432.49 -1.54 -0.35% Pre-Market
2026-10-16 • USD

Key Metrics

Market Cap 233.82B
EV 277.13B
Shares Out 540.63M
Revenue (ttm) 38.09B
Net Income 8.74B
Beta —
P/E —
Forward P/E —
EPS (ttm) $16.09
P/S 6.13
P/B 19.98
P/FCF 22.95
P/C 18.72
EV/Sales 7.27
EV/EBITDA 16.98
ROA 9.41%
ROE 82.07%
ROIC 14.08%
Gross Margin —
Oper. Margin 29.99%
Profit Margin 22.95%
Debt/Eq 4.90
LT Debt/Cap 81.61%
Quick Ratio 0.95
Current Ratio 1.37
Book/sh 21.64
Cash/sh 25.91
Div Yield 2.27%
Div TTM $9.80
Payout Ratio 60.91%
SMA20 4.62%
SMA50 4.21%
SMA200 17.24%
Volume 2,567,330
Avg Volume 2.81M
Rel Volume 0.91
Perf Week 3.57%
Perf Month 12.15%
Perf Quarter 18.07%
Perf Half Y 21.73%
Perf YTD 32.13%
Perf Year 44.74%
Perf 3Y 54.13%
Perf 5Y 109.15%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $2.3800
TTM Yield 2.27%
TTM Amount $9.80
Payout Ratio 60.91%
3-Yr Growth (CAGR) 6.71%
5-Yr Growth (CAGR) 8.05%

Last 12 Payouts

Period Ex-Date Amount / Share
Q4 2025 ~2026-04-01 $2.3800
Q1 2026 ~2026-03-31 $2.5200
Q1 2025 ~2025-12-31 $2.5200
Q3 2025 ~2025-09-30 $2.3800
Q4 2024 ~2025-04-01 $2.2500
Q1 2025 ~2025-03-31 $2.3800
Q1 2024 ~2024-12-31 $2.3800
Q3 2024 ~2024-09-30 $2.2500
Q1 2024 ~2024-03-31 $2.2500
Q4 2023 ~2024-03-31 $2.1300
Q3 2023 ~2023-12-31 $2.2500
Q3 2023 ~2023-09-30 $2.1300

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Amgen Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and delivers human therapeutics. For more than 45 years, Amgen's mission has been to serve…

Name
Amgen Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Robert A. Bradway · Chairman of the Board, Chief Executive Officer and President
Employees
—
IPO Date
2018-05-01
Phone
(805) 447-1000
Address
One Amgen Center Drive, Thousand Oaks, CA 91320-1799
Website
www.amgen.com

Key Executives

Name Title FY Pay
Brian J. Druker Director —
Michael V. Drake Director —
Wanda M. Austin Director —
Robert A. Eckert Lead Independent Director —
Robert A. Bradway Chairman of the Board, Chief Executive Officer and President —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.